BR9914996A - Stimulating compositions for improved growth - Google Patents
Stimulating compositions for improved growthInfo
- Publication number
- BR9914996A BR9914996A BR9914996-6A BR9914996A BR9914996A BR 9914996 A BR9914996 A BR 9914996A BR 9914996 A BR9914996 A BR 9914996A BR 9914996 A BR9914996 A BR 9914996A
- Authority
- BR
- Brazil
- Prior art keywords
- improved
- improved growth
- release
- growth
- stimulating compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Patente de Invenção:<B>''COMPOSIçõES ESTIMULANTES DE CRESCIMENTO MELHORADO''<D>. Um estimulante de peso e crescimento melhorado para animais domésticos tais como gado, porcos e ovelhas compreendendo um agente anabólico que é subcutaneamente administrado na forma de uma formulação de implante de liberação dual. Ganhos aumentados são particularmente melhorados, quando zeranol é administrado em uma formulação de liberação imediata e de liberação controlada que permite uma injeção de dosagem a um só tempo.Invention Patent: <B> '' STIMULANT COMPOSITIONS FOR IMPROVED GROWTH '' <D>. An improved weight and growth stimulant for domestic animals such as cattle, pigs and sheep comprising an anabolic agent that is subcutaneously administered in the form of a dual release implant formulation. Increased gains are particularly improved when zeranol is administered in an immediate-release and controlled-release formulation that allows a single dose injection.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18594498A | 1998-11-04 | 1998-11-04 | |
PCT/US1999/023993 WO2000025743A2 (en) | 1998-11-04 | 1999-11-02 | Improved growth stimulant compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9914996A true BR9914996A (en) | 2001-07-10 |
Family
ID=22683037
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9914996-6 BRPI9914996B8 (en) | 1998-11-04 | 1999-11-02 | Anabolic implant composition and process to stimulate increased growth rate, greater amount of growth and greater feed efficiency in an animal. |
BR9914996-6A BR9914996A (en) | 1998-11-04 | 1999-11-02 | Stimulating compositions for improved growth |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9914996-6 BRPI9914996B8 (en) | 1998-11-04 | 1999-11-02 | Anabolic implant composition and process to stimulate increased growth rate, greater amount of growth and greater feed efficiency in an animal. |
Country Status (11)
Country | Link |
---|---|
AR (1) | AR025133A1 (en) |
AU (1) | AU777393B2 (en) |
BR (2) | BRPI9914996B8 (en) |
CA (1) | CA2348841C (en) |
CO (1) | CO5140100A1 (en) |
CR (1) | CR6351A (en) |
MY (1) | MY134868A (en) |
PE (1) | PE20001092A1 (en) |
TW (1) | TWI250027B (en) |
WO (1) | WO2000025743A2 (en) |
ZA (1) | ZA200103494B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020131988A1 (en) * | 1999-12-16 | 2002-09-19 | Foster Todd P. | Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
US6953586B1 (en) * | 2000-06-08 | 2005-10-11 | Ivy Animal Health, Inc. | Growth promoting pharmaceutical implant |
ES2948624T3 (en) | 2020-11-19 | 2023-09-14 | Fis Fabbrica Italiana Sintetici Spa | Improved process for the preparation of trenbolone and/or trenbolone acetate |
EP4001288A1 (en) | 2020-11-19 | 2022-05-25 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit |
EP4000688A1 (en) | 2020-11-19 | 2022-05-25 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of trenbolone acetate having a definite particle size distribution |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2573307B1 (en) * | 1984-11-22 | 1988-06-10 | Virbac Ctre Rech Biolog | EXTENDED RELEASE ANABOLIZING IMPLANTS |
US4670249A (en) * | 1985-04-12 | 1987-06-02 | International Minerals & Chemical Corp. | Growth-promoting compositions |
US5219572A (en) * | 1989-03-17 | 1993-06-15 | Pitman-Moore, Inc. | Controlled release delivery device for macromolecular proteins |
US5747060A (en) * | 1996-03-26 | 1998-05-05 | Euro-Celtique, S.A. | Prolonged local anesthesia with colchicine |
US5874098A (en) * | 1997-05-28 | 1999-02-23 | Ivy Laboratories, Inc. | Pellet implant system |
-
1999
- 1999-11-02 WO PCT/US1999/023993 patent/WO2000025743A2/en active IP Right Grant
- 1999-11-02 TW TW088119044A patent/TWI250027B/en not_active IP Right Cessation
- 1999-11-02 BR BRPI9914996-6 patent/BRPI9914996B8/en unknown
- 1999-11-02 BR BR9914996-6A patent/BR9914996A/en not_active IP Right Cessation
- 1999-11-02 CA CA002348841A patent/CA2348841C/en not_active Expired - Lifetime
- 1999-11-02 CO CO99069032A patent/CO5140100A1/en unknown
- 1999-11-02 AR ARP990105535A patent/AR025133A1/en active IP Right Grant
- 1999-11-02 AU AU30967/00A patent/AU777393B2/en not_active Expired
- 1999-11-03 PE PE1999001104A patent/PE20001092A1/en not_active IP Right Cessation
- 1999-11-03 MY MYPI99004773A patent/MY134868A/en unknown
-
2001
- 2001-04-20 CR CR6351A patent/CR6351A/en not_active Application Discontinuation
- 2001-04-30 ZA ZA200103494A patent/ZA200103494B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI9914996A (en) | 2001-07-10 |
BRPI9914996B8 (en) | 2021-07-06 |
AU777393B2 (en) | 2004-10-14 |
CA2348841C (en) | 2007-04-17 |
MY134868A (en) | 2007-12-31 |
PE20001092A1 (en) | 2000-10-31 |
BRPI9914996B1 (en) | 2011-11-01 |
WO2000025743A3 (en) | 2000-08-24 |
CR6351A (en) | 2003-11-20 |
CA2348841A1 (en) | 2000-05-11 |
TWI250027B (en) | 2006-03-01 |
AU3096700A (en) | 2000-05-22 |
AR025133A1 (en) | 2002-11-13 |
WO2000025743A2 (en) | 2000-05-11 |
ZA200103494B (en) | 2002-07-30 |
CO5140100A1 (en) | 2002-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2603086T3 (en) | Use of daptomycin | |
CY1105000T1 (en) | USE OF SPINOSADI OR A COMPOSITION OF SPINOSADI CONTENT | |
BR0306982A (en) | Compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, methods to reduce the calcium conductance of a cell capsaicin receptor, to inhibit the binding of vanilloid ligand to a capsaicin receptor in vitro and in a patient, to treat a condition responsive to modulation of the capsaicin receptor in a patient, to treat pain in a patient, to treat itching in a patient, to treat coughing or hiccups in a patient, to promote weight loss in an obese patient, and to determine the presence or absence capsaicin receptor in a sample, packaged pharmaceutical preparation, and use of a compound | |
BR0015974A (en) | Use of levetiracetam, pharmaceutical composition, use of a pharmaceutical composition and methods to treat a patient administered with an amount of at least one compound and a disease and to selectively potentiate the therapeutic effect of a compound | |
BR0317747A (en) | Method of concomitant therapeutic treatment of an individual, pharmaceutical composition, kit, use of a first agent and a second agent, and methods of preventing or treating amyloid-b-related disease, alzheimer's disease and mild cognitive impairment | |
BR0314356A (en) | Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods using the same | |
BR0114799A (en) | Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents | |
BR9815499A (en) | Prolonged anesthesia in joints and body spaces. | |
BR0013010A (en) | Formulation of moxifloxacin sodium chloride | |
BR0214610A (en) | Controlled release polymeric compositions of bone growth promoting compounds | |
BRPI0507824A (en) | hydroxyapatite, process for the preparation of a radionuclide-labeled hydroxyapatite particulate, pharmaceutical composition, use of hydroxyapatite and an alpha-emitting radionuclide or a beta-emitting radionuclide, device, and, method of radiochemical treatment of a human or human individual non-human animal needing the same | |
BRPI0517719A (en) | transmucosal veterinary composition comprising detomidine | |
ES2176487T3 (en) | COMPOSITIONS OF COSMETIC AND / OR PHARMACEUTICAL ANTI-PRURIGINAL COMPOUNDS OF ONE OR MISCELLANEOUS LOCAL ANESTHETICS AND ONE OR VARIOUS ASTRINGENTS. | |
AR098251A2 (en) | USE OF AIVLOSIN OR AN ACID ADDITION SALT OF THE SAME PHARMACOLOGICALLY ACCEPTED FOR THE PREPARATION OF A VETERINARY USE MEDICINAL PRODUCT, A FOOD FOR CORRAL BIRDS OR PIGS, A STABLE COVERED COMPOSITION TO BE ADDED TO THIS FOOD | |
SE0002754D0 (en) | New pharmaceutical combination formulation and method of treatment with the combination | |
AR044236A2 (en) | USE OF A COMPOSITION THAT INCLUDES LIVING EIMERIA SPORTS | |
TR200002969T2 (en) | Pharmaceutical composition. | |
BR0206576A (en) | Pharmaceutical composition containing aminoacetonitrile compounds and their use for the preparation of a pharmaceutical composition for treating endoparasitic pests in animals | |
BR9916575A (en) | Pharmaceutical composition of controlled release with tilidine mesylate as active substance | |
BR9914996A (en) | Stimulating compositions for improved growth | |
BR9106676A (en) | PEPTIDE, PROCESS TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMAL, PHARMACEUTICAL COMPOSITION TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMALS, USE OF THE COMPOUND AND PROCESS TO PROMOTE THE LIBERATION IN THE ELEVATION BLOOD | |
AR019579A1 (en) | USE OF AN INITIATOR OF THE SEXUAL RESPONSE OF THE CENTRAL NERVOUS SYSTEM FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE STANDARDIZATION OF THE CHRONOMETRATION OF THE SEXUAL RESPONSE OR FOR THE PROPHYLAXIS OR REDUCTION OF THE MULTIFUL LESIAN NUMBER | |
BR0210063A (en) | Stable composition and use | |
KR930702016A (en) | Osteoporosis Drug | |
UA85060C2 (en) | Bioactive supplement preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO ATENDE AOS REQUISITO DE PATENTEABILIDADE CONFORME O DISPOSTO NOS ARTIGOS 8O COMBINADO COM 13 DA LEI 9.279/96. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/11/2011, OBSERVADAS AS CONDICOES LEGAIS. NA FOLHA 132, LINHA 29, ONDE SE LE: "...NA ETAPA 9(A) E 9(B); LEIA-SE: "...NAS ETAPAS (A) E (B)" |
|
B25D | Requested change of name of applicant approved | ||
B25G | Requested change of headquarter approved | ||
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/11/99, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 02.11.2019 |
|
B16B | Notification of grant cancelled [chapter 16.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 16.3 NA RPI NO 2635 DE 06/07/2021 POR TER SIDO INDEVIDA, UMA VEZ QUE A PATENTE ESTA RELACIONADA A PRODUTO VETERINARIO. |
|
B21I | Extinguishment of a patent or of a certificate of addition of invention: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 21.1 NA RPI NO 2656 DE 30/11/2021 POR TER SIDO INDEVIDA. |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 01/11/2021. |